Found 4 Enz. Inhib. hit(s) with Target = 'Lysyl oxidase homolog 2' and Ligand = 'BDBM50526731' TargetLysyl oxidase homolog 2(Homo sapiens (Human))
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
Affinity DataIC50: 65nMAssay Description:LOXL2 batch is obtained from R&D systems/Bio-techne. Incubate for 20 hours at room temp on a plate shaker.More data for this Ligand-Target Pair
TargetLysyl oxidase homolog 2(Homo sapiens (Human))
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
Affinity DataIC50: 65nMAssay Description:MAO-Glo Assay Kit: Promega, Cat No. V1402MAO-A Enzyme: Promega, Cat No. V1452Clorgyline: Sigma, Cat No. M3778 (50 mg)Assay Plates:96 well white polys...More data for this Ligand-Target Pair
TargetLysyl oxidase homolog 2(Homo sapiens (Human))
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
Affinity DataIC50: 65nMAssay Description:10. Incubate for 20 hrs at room temp on a plate shaker, protected from light.More data for this Ligand-Target Pair
TargetLysyl oxidase homolog 2(Homo sapiens (Human))
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
The Institute Of Cancer Research: Royal Cancer Hospital
US Patent
Affinity DataIC50: 380nMAssay Description:Inhibition of human C-terminal His10-tagged LOXL2 (Met1 to Gln774 residues) expressed in mouse NS0 cells using cadaverine hydrochloride as substrate ...More data for this Ligand-Target Pair
